Novavax’s stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidates

Date:

October 16, 2024

Novavax Inc.’s stock tumbled 16% early Wednesday after the company said the FDA has placed a clinical hold on its COVID-19-and-flu combination and stand-alone flu vaccine candidates, following a case of motor neuropathy in a participant in a mid-stage trial.

Source link

Amazon, Google make dueling nuclear investments to power data centers with clean energy

Leeds duo Daniel James and Manor Solomon return from injury absences

Alexandra Williams

Alexandra Williams is a writer and editor. Angeles. She writes about politics, art, and culture for LinkDaddy News.

Novavax’s stock slides 16% after FDA puts clinical hold on COVID and flu vaccine candidates

Recent posts

Fed rate cuts may make ether more attractive after being left behind by bitcoin

This part of the Treasury market may move the most on a Fed interest-rate cut

WeightWatchers’ stock soars after adding compounded GLP-1 treatment to its offering

Helen of Troy’s stock plunges, as health of consumers and retailers has worsened

Freight demand is weak, but cost cuts help C.H. Robinson boost profits. Shares are rallying.

ASML results could provide insight into AI, China demand

J&J to acquire V-Wave for up to $1.7 billion in play for heart-failure device

Eli Lilly’s Zepbound pricing shuffle leaves some patients fearing higher costs

Boeing files NLRB unfair-labor-practice charge against union amid ongoing machinist strike

Medicare patients could get emergency treatment at home under new bill

Mohawk Industries’ stock rallies as flooring-products maker draws upgrade on boosted profit view

Edwards Lifesciences to get $4.2 billion in cash for sale of critical-care group

Fertility-benefits provider Progyny’s stock on track for biggest-ever decline after losing ‘significant’ client

Fed’s Barkin: More data is needed before any changes are made to interest rates

Nvidia’s bonds in demand heading into earnings, as investors eye companies expected to benefit from AI spending

Related articles

Bond investors position for new debt from Goldman Sachs and Morgan Stanley

Parents trust Republicans more on the economy, but they’re split on Trump vs. Harris

ASML says chip-market slump will mainly impact sales to China

Holiday sales growth could slow to pre-pandemic levels, retail group says

ASML results could provide insight into AI, China demand

Hint of ‘very high’ consumer inflation expectations raises risks for Treasury market

Why Saudi Arabia may ‘open the spigot’ on oil production — and crater crude prices

Hedge-fund manager who could be Trump Treasury secretary says tariffs can be negotiated lower

Company

Follow us